title: Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism.
abstract: OBJECTIVE
  To test the hypothesis that a low D-dimer level has a high negative predictive value for acute pulmonary embolism (PE) among patients undergoing diagnostic pulmonary angiography.
  
  
  METHODS
  Blinded comparison of quantitative plasma D-dimer levels, measured using a monoclonal antibody assay, with pulmonary angiographic results from 173 patients with suspected acute PE.
  
  
  METHODS
  Tertiary care setting at fur participating institutions.
  
  
  METHODS
  Plasma samples were analyzed in 173 patients who underwent diagnostic pulmonary arteriography for suspected acute PE.
  
  
  METHODS
  Sensitivity, specificity, and predictive values of quantitative plasma D-dimer levels for the diagnosis of PE, using pulmonary angiographic data as the criterion standard test.
  
  
  RESULTS
  Of 35 patients with D-dimer values less than 500 ng/mL, only three had abnormal pulmonary angiograms. The negative predictive value of a plasma D-dimer level less than 500 ng/mL for acute PE was 91.4% (95% confidence interval [CI], 76.9% to 98.2%). D-dimer levels were greater than 500 ng/mL in 42 of 45 patients with PE and in 96 of 128 patients without PE (P = .016). Sensitivity, specificity, and positive predictive value of a plasma D-dimer level greater than 500 ng/mL for acute PE were 93.3% (95% CI, 81.7% to 98.6%), 25.0% (95% CI, 17.5% to 32.5%), and 30.4% (95% CI, 22.8% to 38.1%), respectively.
  
  
  CONCLUSIONS
  The results of our study indicate that quantitative plasma D-dimer levels can be useful in screening patients with suspected PE who require pulmonary angiography. Plasma D-dimer values less than 500 ng/mL may obviate the need for pulmonary angiography, particularly among medical patients for whom the clinical suspicion of PE is low. The plasma D-dimer value, assayed using a commercially available enzyme-linked immunosorbent assay kit, is a sensitive but nonspecific test for the presence of acute PE.
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
authors.forename: S Z
authors.initials: SZ
authors.lastname: Goldhaber
authors.forename: G R
authors.initials: GR
authors.lastname: Simons
authors.forename: C G
authors.initials: CG
authors.lastname: Elliott
authors.forename: W D
authors.initials: WD
authors.lastname: Haire
authors.forename: R
authors.initials: R
authors.lastname: Toltzis
authors.forename: S C
authors.initials: SC
authors.lastname: Blacklow
authors.forename: M H
authors.initials: MH
authors.lastname: Doolittle
authors.forename: D S
authors.initials: DS
authors.lastname: Weinberg
mesh_terms: D000328:Adult; D000368:Aged; D000792:Angiography; D000933:Antifibrinolytic Agents / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011655:Pulmonary Embolism / Q000097:blood* / Q000000981:diagnostic imaging*; D012680:Sensitivity and Specificity
chemical_list: D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D